• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Study on the Correlation Factors of 13, 14 Groups Lymph Node Metastasis of 
Non-small Cell Lung Cancer].[非小细胞肺癌13、14组淋巴结转移相关因素研究]
Zhongguo Fei Ai Za Zhi. 2017 Apr 20;20(4):248-252. doi: 10.3779/j.issn.1009-3419.2017.04.04.
2
[Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].[非小细胞肺癌患者纵隔淋巴结转移的危险因素分析及术前纵隔镜检查策略]
Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):456-9.
3
New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non-small cell lung cancer.评估 N1 分期的新视角:非小细胞肺癌的外周淋巴结转移状态。
Thorac Cancer. 2019 Dec;10(12):2253-2258. doi: 10.1111/1759-7714.13213. Epub 2019 Oct 16.
4
The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.右上中叶非小细胞肺癌纵隔淋巴结转移对预后的影响
J Thorac Oncol. 2011 Mar;6(3):494-9. doi: 10.1097/JTO.0b013e31820b8891.
5
Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.临床Ⅰ期非小细胞肺癌患者淋巴结转移的预测因素。
Ann Thorac Surg. 2013 Jul;96(1):239-45. doi: 10.1016/j.athoracsur.2013.03.050. Epub 2013 May 11.
6
Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.肺癌中N1和N2站之间的边界:下叶肿瘤淋巴结转移模式的经验教训
J Thorac Cardiovasc Surg. 2005 Apr;129(4):825-30. doi: 10.1016/j.jtcvs.2004.06.016.
7
[Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].[临床I a期非小细胞肺癌淋巴结清扫的适宜范围]
Ai Zheng. 2007 Mar;26(3):303-6.
8
Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.氟-18 氟代脱氧葡萄糖标准摄取值对临床Ⅰ a 期非小细胞肺癌系统淋巴结清扫或采样的更好选择的预测价值。
Clin Lung Cancer. 2013 Sep;14(5):568-73. doi: 10.1016/j.cllc.2013.02.002. Epub 2013 Jul 5.
9
Size of metastatic and nonmetastatic mediastinal lymph nodes in non-small cell lung cancer.非小细胞肺癌中转移性和非转移性纵隔淋巴结的大小
J Thorac Oncol. 2006 Nov;1(9):949-52.
10
Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.淋巴结受累与病理T1期浸润性非小细胞肺癌预后的相关性
World J Surg Oncol. 2017 Mar 17;15(1):64. doi: 10.1186/s12957-017-1098-3.

本文引用的文献

1
[Role of pulmonary segmental and sub-segmental lymph nodes in pathological staging of lung cancer].[肺段及亚段淋巴结在肺癌病理分期中的作用]
Zhonghua Yi Xue Za Zhi. 2010 Jul 20;90(27):1873-6.
2
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.肺癌辅助顺铂评估:LACE协作组的汇总分析
J Clin Oncol. 2008 Jul 20;26(21):3552-9. doi: 10.1200/JCO.2007.13.9030. Epub 2008 May 27.
3
Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).非小细胞肺癌I期和II期的治疗:美国胸科医师学会循证临床实践指南(第2版)
Chest. 2007 Sep;132(3 Suppl):234S-242S. doi: 10.1378/chest.07-1378.
4
Analyses of segmental lymph node metastases and intrapulmonary metastases of small lung cancer.小肺癌的肺段淋巴结转移及肺内转移分析
Ann Thorac Surg. 2000 Nov;70(5):1624-8. doi: 10.1016/s0003-4975(00)01923-8.
5
Lymph node sampling in lung cancer: how should it be done?肺癌中的淋巴结采样:应如何进行?
Eur J Cardiothorac Surg. 1999 Sep;16 Suppl 1:S17-24. doi: 10.1016/s1010-7940(99)00178-5.
6
Regional lymph node classification for lung cancer staging.用于肺癌分期的区域淋巴结分类。
Chest. 1997 Jun;111(6):1718-23. doi: 10.1378/chest.111.6.1718.

[非小细胞肺癌13、14组淋巴结转移相关因素研究]

[Study on the Correlation Factors of 13, 14 Groups Lymph Node Metastasis of 
Non-small Cell Lung Cancer].

作者信息

Zhang Lei, Jiya Buren, Wang Yufei, Han Batel, Guo Zhanlin

机构信息

Department of Thoracic Surgery, The Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010050, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2017 Apr 20;20(4):248-252. doi: 10.3779/j.issn.1009-3419.2017.04.04.

DOI:10.3779/j.issn.1009-3419.2017.04.04
PMID:28442013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5999675/
Abstract

BACKGROUND

Lymph node metastasis is one of the important factors affecting the tumor-node-matastasis (TNM) staging of lung cancer. In patients with surgery, 13 groups and 14 groups of lymph nodes ignored because of the deep hidden in the lung. In this paper, the positive detection rate of 13 groups and the 14 groups of lymph nodes in non-small cell lung cancer (NSCLC) and their effects on pathological stage were studied.

METHODS

100 cases of NSCLC were collected from the Affiliated Hospital of Inner Mongolia Medical University as the research object, cut out the intrathoracic 2-12 group, 13, 14 lymph node metastasis rate for pathological examination, relationship factors of statistical analysis of the size of primary tumor, location, pathological type and lymph node.

RESULTS

100 cases of patients with intrathoracic lymph node metastasis rate was 47.0%, with the 10-12 groups lymph node, N2 lymph nodes, 13, 14 groups lymph node positive rate had significant differences (P<0.05); T stage 13, 14 groups of lymph node detection rate has statistically significant difference (P<0.05); peripheral and central NSCLC stage N1 undetected rate no statistical difference (P>0.05); various pathological types of tumors between N1 missed rate had no significant difference (P>0.05). In addition, 12 patients were found to have non-tumor-derived lobe lymph node metastasis.

CONCLUSIONS: It is necessary to detect the metastatic lymph nodes of 13,14 group and non-tumor-derived lobe in NSCLC. It is helpful to obtain accurate TNM staging and to guide postoperative treatment.
.

摘要

背景

淋巴结转移是影响肺癌肿瘤-淋巴结-转移(TNM)分期的重要因素之一。在手术患者中,第13组和第14组淋巴结因深藏于肺内而被忽视。本文研究非小细胞肺癌(NSCLC)中第13组和第14组淋巴结的阳性检出率及其对病理分期的影响。

方法

收集内蒙古医科大学附属医院100例NSCLC患者作为研究对象,切除胸内第2 - 12组、第13、14组淋巴结进行病理检查,统计分析原发肿瘤大小、位置、病理类型与淋巴结转移的相关因素。

结果

100例患者胸内淋巴结转移率为47.0%,与第10 - 12组淋巴结、N2淋巴结、第13、14组淋巴结阳性率有显著差异(P<0.05);T分期中第13、14组淋巴结检出率有统计学差异(P<0.05);周围型和中央型NSCLC的N1未检出率无统计学差异(P>0.05);各病理类型肿瘤之间N1漏诊率无显著差异(P>0.05)。此外,发现12例患者有非肿瘤来源叶的淋巴结转移。

结论

NSCLC中检测第13、14组及非肿瘤来源叶的转移淋巴结很有必要。有助于获得准确的TNM分期并指导术后治疗。